Esophageal Diseases
Welcome,         Profile    Billing    Logout  
 128 Companies   121 Products   121 Products   104 Mechanisms of Action   7 Trials   1812 News 


«12...678910111213141516...3637»
  • ||||||||||  cendakimab (CC-93538) / AbbVie, BMS
    Trial primary completion date:  HEROES: Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis (clinicaltrials.gov) -  May 28, 2016   
    P2,  N=90, Active, not recruiting, 
    Recruiting --> Completed | N=45 --> 33 Trial primary completion date: Jul 2016 --> Feb 2016
  • ||||||||||  Enrollment open, Trial initiation date:  HX4 SD: Tumor Hypoxia With HX4 PET in Several Diseases (clinicaltrials.gov) -  May 25, 2016   
    P2,  N=120, Recruiting, 
    N=45 --> 21 | Suspended --> Terminated; Interim analysis Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> May 2016
  • ||||||||||  Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date:  MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer (clinicaltrials.gov) -  May 13, 2016   
    P1,  N=0, Withdrawn, 
    Recruiting --> Completed N=10 --> 0 | Initiation date: Feb 2016 --> May 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2019 --> May 2016
  • ||||||||||  New P4 trial:  RELIEF Europe Study (clinicaltrials.gov) -  May 5, 2016   
    P4,  N=100, Recruiting, 
  • ||||||||||  dexamethasone injection / Generic mfg.
    Trial primary completion date, Surgery:  DysDexVSSal: Dysphagia Following Anterior Cervical Spine Surgery; Steroid vs Saline (clinicaltrials.gov) -  May 4, 2016   
    P=N/A,  N=74, Active, not recruiting, 
    Recruiting --> Completed | N=30 --> 24 | Trial primary completion date: Jul 2017 --> Oct 2015 Trial primary completion date: Mar 2016 --> Sep 2016
  • ||||||||||  Dexilant (dexlansoprazole) / Takeda
    Enrollment closed, Trial primary completion date:  Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease (clinicaltrials.gov) -  May 3, 2016   
    P4,  N=300, Active, not recruiting, 
    Initiation date: Jul 2011 --> Nov 2004 | Trial primary completion date: Jun 2029 --> Jul 2010 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Jun 2016
  • ||||||||||  Biomarker, Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease (clinicaltrials.gov) -  May 3, 2016   
    P=N/A,  N=75, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Jun 2016 Recruiting --> Completed | N=156 --> 75 | Initiation date: Oct 2013 --> Mar 2013 | Trial primary completion date: Jun 2015 --> Aug 2014
  • ||||||||||  Enrollment open, Trial primary completion date:  The Captivator EMR Registry (clinicaltrials.gov) -  Apr 27, 2016   
    P=N/A,  N=300, Recruiting, 
    Active, not recruiting --> Completed | N=50 --> 39 Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Biomarker, Enrollment change, Trial termination, Trial primary completion date:  Permission to Collect Blood Over Time for Research (clinicaltrials.gov) -  Apr 25, 2016   
    P=N/A,  N=104, Terminated, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2016 --> Dec 2016 N=345 --> 104 | Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Oct 2011; Accrual issues - Low Accrual
  • ||||||||||  Enrollment closed:  Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? (clinicaltrials.gov) -  Apr 22, 2016   
    P0,  N=27, Active, not recruiting, 
    N=345 --> 104 | Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Oct 2011; Accrual issues - Low Accrual Enrolling by invitation --> Active, not recruiting
  • ||||||||||  evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
    Enrollment change, Trial withdrawal, Trial primary completion date, Combination therapy:  Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. (clinicaltrials.gov) -  Apr 21, 2016   
    P1,  N=0, Withdrawn, 
    Trial primary completion date: Jun 2015 --> Jun 2016 N=18 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Apr 2016
  • ||||||||||  Trial primary completion date, HEOR:  Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer (clinicaltrials.gov) -  Apr 19, 2016   
    P=N/A,  N=100, Active, not recruiting, 
    Recruiting --> Completed | N=15 --> 10 | Trial primary completion date: Dec 2013 --> Apr 2014 Trial primary completion date: Jun 2016 --> Jun 2017
  • ||||||||||  Trial primary completion date:  Study to Image the Esophagus Using the OFDI Capsule (clinicaltrials.gov) -  Apr 18, 2016   
    P1,  N=54, Recruiting, 
    Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Oct 2015 --> Oct 2017
  • ||||||||||  Enrollment change, Trial termination, Biopsy:  WavSTAT (clinicaltrials.gov) -  Apr 14, 2016   
    P=N/A,  N=47, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Jun 2017 N=250 --> 47 | Suspended --> Terminated; Study has been terminated for inadequate results
  • ||||||||||  Trial primary completion date:  Assessing Risk of Food Insecurity Within Households of Children With Food Allergy (clinicaltrials.gov) -  Apr 14, 2016   
    P=N/A,  N=650, Enrolling by invitation, 
    N=250 --> 47 | Suspended --> Terminated; Study has been terminated for inadequate results Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Enrollment change, Trial withdrawal:  Validity of a New Stroke Dysphagia Screening Tool (clinicaltrials.gov) -  Apr 11, 2016   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2014 --> Dec 2015 N=18 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Trial completion:  IMRT Tomotherapy for Esophagus Cancer (clinicaltrials.gov) -  Apr 7, 2016   
    P1,  N=26, Completed, 
    N=36 --> 0 | Active, not recruiting --> Withdrawn Active, not recruiting --> Completed
  • ||||||||||  Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
    Trial primary completion date, Metastases:  Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer (clinicaltrials.gov) -  Mar 30, 2016   
    P2/3,  N=80, Recruiting, 
    N=50 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Dec 2015 --> Dec 2017